2011 Gordon Research Conference on Tuberculosis Drug Development

描述(申请人提供)：此申请寻求部分支持2011年戈登研究会议(GRC)的结核病(TB)药物开发将于7月3-8日在意大利Il Ciocco举行。这个两年一度的会议是最重要的全球会议，汇聚了学术界和工业界的研究人员，共同关注这一问题。结核病的治疗仍然是一项持续的挑战，特别是在抗药性问题日益严重的情况下。新的治疗方法可以极大地改善药物敏感和耐药疾病的治疗结果，因此人们正在积极寻找具有新作用模式的化合物。结核病药物发现是一个极其活跃的研究领域，越来越多地吸引着具有不同背景的研究人员，包括微生物学、化学、药理学、医学和临床研究。2011年关于结核病药物开发的全球研究报告将为新的研究人员提供一个机会，让他们了解该领域的挑战，并让经验丰富的研究人员在特别关键的关头讨论最新的发现。 公共卫生相关性：结核病仍然是世界上主要的死亡原因之一，发病率继续攀升。结核病的新疗法可以治愈这种疾病，并限制其传播。在此，我们请求为这一领域的两年一度的重大科学会议--2011年戈登结核病药物开发研究会议--提供资金。

DESCRIPTION (provided by applicant): This application seeks partial support for the 2011 Gordon Research Conference (GRC) on Tuberculosis (TB) Drug Development to be held in Il Ciocco, Italy from July 3rd - 8th. This biennial event is the most important global conference bringing together researchers from both academia and industry to focus on this problem. Treatment of TB remains a continuing challenge particularly with the increasing problem of drug resistance. New treatments could dramatically improve the results of therapy of both drug-sensitive and drug-resistant disease and compounds with new modes-of-action are being actively sought for this reason. TB drug discovery is an extremely vigorous area of research and is increasingly attracting investigators with diverse backgrounds, including microbiology, chemistry, pharmacology, medicine and clinical research. The 2011 GRC on TB Drug Development will provide an opportunity for new investigators to understand the challenges in the field and for experienced researchers to discuss the latest findings at a particularly critical juncture. PUBLIC HEALTH RELEVANCE: Tuberculosis remains one of the leading causes of death in the world and rates of disease continue to climb. New treatments for tuberculosis could cure this disease and limit its spread. Here we request funding for the major biennial scientific meeting in this area, the 2011 Gordon Research Conference on Tuberculosis Drug Development.